Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/192
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Otaiku, Eyiowuawi Toluwalase | - |
dc.date.accessioned | 2022-06-24T08:47:21Z | - |
dc.date.available | 2022-06-24T08:47:21Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Otaiku Eyiowuawi Toluwalase (2019). Molecular Characterization of Fungi from Pharmaceutical Products | en_US |
dc.identifier.other | 15010101013 | - |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/192 | - |
dc.description.abstract | Studies on Fungi isolated from pharmaceutical products from pharmacy and stores were carried out between the month of April 2019 and July 2019. Collection, isolation, characterization and identification of the isolated Fungi were achieved using both conventional laboratory methods and molecular methods (DNA extraction, PCR and DNA sequencing).Thirteen fungi was isolated out of which seven fungal species were identified and they include Aspergillus tamari strain A, Aspergillus tubingenesis strain, Aspergillus tamari strain B, Aspergillus ellipticus, Aspergillus niger strain A, Aspergillus niger strain B, Aspergillus niger strain C, from the pharmaceutical drugs sampled using 3 protocols. The result of the BLAST DNA sequence database of the isolated fungi revealed that no sequence data was 100% homologous with those in the Gene bank. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Mountain Top University | en_US |
dc.subject | DNA | en_US |
dc.subject | Fungi | en_US |
dc.title | Molecular Characterization of Fungi from Pharmaceutical Products | en_US |
dc.type | Other | en_US |
Appears in Collections: | Microbiology |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
otaiku-eyiowuawi-toluwalase-microbiology-2019docx.pdf | 654.17 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.